Rating History for Trillium Therapeutics (TRIL) by Benchmark

More Stocks Rated by Benchmark | Latest Ratings for TRIL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/17/2021 Aydin Huseynov Downgrade Hold
(Buy)		 N/A
(N/A)		 18.44
(19.86)		 7.7% Details